0001236031-11-000028.txt : 20111207
0001236031-11-000028.hdr.sgml : 20111207
20111207165309
ACCESSION NUMBER: 0001236031-11-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111205
FILED AS OF DATE: 20111207
DATE AS OF CHANGE: 20111207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KERSTEN GEERT R
CENTRAL INDEX KEY: 0001236030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 111249028
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2011-12-05
0
0000725363
CEL SCI CORP
cvm
0001236030
KERSTEN GEERT R
1
1
0
0
Chief Executive Officer
Options
2011-12-05
4
D
0
1568000
0
D
Common Stock
1568000
9278609
D
Options
0.32
2011-12-05
4
A
0
1254400
0
A
2011-12-05
2016-12-01
Common Stock
1254400
10533009
D
Multiple option grants with exercise prices between $0.54 and $1.94
Agreed to reduction of shares of common stock issuable upon exercise of options in return for a reduction in the exercise price.
Multiple option grants exercisable between 11/1/90 and 9/2/05
Multiple option grants with expiration dates between 3/14/12 and 9/2/14
Geert Kersten
2011-12-07